Can Improved Prescription Medication Labeling Influence Adherence to Chronic Medications? An Evaluation of the Target Pharmacy Label
- William H. Shrank MD, MSHS,
- Patrick P. Gleason Pharm. D.,
- Claire Canning MA,
- Carol Walters MBA,
- Alan H. Heaton Pharm. D.,
- Saira Jan Pharm. D.,
- Amanda Patrick MS,
- M. Alan Brookhart PhD,
- Sebastian Schneeweiss MD ScD,
- Daniel H. Solomon MD MPH,
- Jerry Avorn MD,
- Niteesh K. Choudhry MD PhD
- … show all 12 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Prescription medication labels contain valuable health information, and better labels may enhance patient adherence to chronic medications. A new prescription medication labeling system was implemented by Target pharmacies in May 2005 and aimed to improve readability and understanding.
We evaluated whether the new Target label influenced patient medication adherence.
DESIGN AND PATIENTS
Using claims from two large health plans, we identified patients with one of nine chronic diseases who filled prescriptions at Target pharmacies and a matched sample who filled prescriptions at other community pharmacies.
We stratified our cohort into new and prevalent medication users and evaluated the impact of the Target label on medication adherence. We used linear regression and segmented linear regression to evaluate the new-user and prevalent-user analyses, respectively.
Our sample included 23,745 Target users and 162,368 matched non-Target pharmacy users. We found no significant change in adherence between new users of medications at Target or other community pharmacies (p = 0.644) after implementing the new label. In prevalent users, we found a 0.0069 percent reduction in level of adherence (95% CI −0.0138-0.0; p < 0.001) and a 0.0007 percent increase in the slope in Target users (the monthly rate of change of adherence) after implementation of the new label (95% CI 0.0001–0.0013; p = 0.001).
We found no changes in adherence of chronic medication in new users, and small and likely clinically unimportant changes in prevalent users after implementation of the new label. While adherence may not be improved with better labeling, evaluation of the effect of labeling on safety and adverse effects is needed.
- Can Improved Prescription Medication Labeling Influence Adherence to Chronic Medications? An Evaluation of the Target Pharmacy Label
Journal of General Internal Medicine
Volume 24, Issue 5 , pp 570-578
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- prescription medication
- Industry Sectors
- William H. Shrank MD, MSHS (1)
- Patrick P. Gleason Pharm. D. (2)
- Claire Canning MA (1)
- Carol Walters MBA (2)
- Alan H. Heaton Pharm. D. (3)
- Saira Jan Pharm. D. (4)
- Amanda Patrick MS (1)
- M. Alan Brookhart PhD (1)
- Sebastian Schneeweiss MD ScD (1)
- Daniel H. Solomon MD MPH (1)
- Jerry Avorn MD (1)
- Niteesh K. Choudhry MD PhD (1)
- Author Affiliations
- 1. Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA
- 2. Prime Therapeutics, Eagan, Minnesota, USA
- 3. Blue Cross Blue Shield of Minnesota, Minnesota, USA
- 4. Horizon Blue Cross Blue Shield of New Jersey, Minnesota, USA